Weiss Multi-Strategy Advisers LLC - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 110 filers reported holding INTERSECT ENT INC in Q1 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2022$2,117,000
+2.6%
75,5690.0%0.05%
+4.3%
Q4 2021$2,064,000
-0.7%
75,569
-1.1%
0.05%
+4.4%
Q3 2021$2,078,000
+202.5%
76,401
+90.2%
0.04%
+200.0%
Q2 2021$687,000
-15.1%
40,174
+3.7%
0.02%
-16.7%
Q1 2021$809,000
-9.9%
38,735
-1.2%
0.02%
+5.9%
Q4 2020$898,000
+36.1%
39,206
-3.1%
0.02%
-5.6%
Q3 2020$660,000
+8.0%
40,450
-10.3%
0.02%0.0%
Q2 2020$611,000
+6.8%
45,104
-6.5%
0.02%
-18.2%
Q1 2020$572,000
-23.4%
48,245
+60.8%
0.02%
+83.3%
Q4 2019$747,000
+75.8%
30,000
+20.0%
0.01%
+33.3%
Q3 2019$425,000
+86.4%
25,000
+150.0%
0.01%
+50.0%
Q2 2019$228,000
-29.2%
10,0000.0%0.01%
-25.0%
Q1 2019$322,000
+14.2%
10,0000.0%0.01%
-33.3%
Q4 2018$282,000
-56.9%
10,000
-42.9%
0.01%
-25.0%
Q2 2018$655,000
+66.7%
17,500
+75.0%
0.02%
+33.3%
Q1 2018$393,00010,0000.01%
Other shareholders
INTERSECT ENT INC shareholders Q1 2021
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 186,561$5,364,0004.51%
First Light Asset Management, LLC 517,121$14,867,0002.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,147,950$61,754,0002.21%
HealthCor Management, L.P. 1,950,000$56,063,0001.86%
PURA VIDA INVESTMENTS, LLC 200,000$5,750,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 112,000$2,469,0001.17%
Broadfin Capital, LLC 234,200$6,733,0000.99%
Lombard Odier Asset Management (USA) Corp 240,000$6,900,0000.51%
PURA VIDA INVESTMENTS, LLC 83,527$2,401,0000.50%
Rock Springs Capital Management LP 460,000$13,225,0000.48%
View complete list of INTERSECT ENT INC shareholders